TREM2 and neoplasm: Triggering receptors expressed on myeloid cells 2 (TREM2) is a broadly expressed PRR on macrophages, dendritic cells, and microglia cells [9, 10], which be considered an important therapeutic target for neurodegenerative disease, infectious disease and tumor immunotherapy [11, 12].